Report cover image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

Publisher Kalorama Information
Published Feb 12, 2018
Length 203 Pages
SKU # KLI15596716

Description

What's Trending in Monoclonal Antibodies (Markets by Structure, by Target, and by Indication)

There are several types of monoclonal antibodies (mAbs) – large protein molecules produced by white blood cells (WBCs) that seek out and destroy harmful foreign substances – on the market and in development. What's Trending in Monoclonal Antibodies looks at the market for these, which are finding wide application in many areas of medicine and biologic science, by structure, by target, and by indication, including the following information: monoclonal antibody revenues by structure, 2017 and forecast 2022 (chimeric, humanized, human, Others); leading chimeric, humanized and human mAb products market, 2017-2022; monoclonal antibody revenues by target, 2017 and forecast 2022 (TNF, CD20, HER2, VEGF, EGFR, PD-1, PD-L1, TNFSF11, IL12/IL23, IL17, IL6, Others); and monoclonal antibody revenues by indication, 2017 and Forecast 2022 (Autoimmune, Oncology, Neurological, Respiratory, Cardio/Blood, Infection, Other).

The report also goes beyond broad indication category to provide detail on the rheumatoid arthritis, Crohn's disease/ulcerative colitis, psoriasis, other autoimmune, cancer (breast cancer, colon cancer, lymphoma, leukemia, myeloma, melanoma), multiple sclerosis, asthma, and macular degeneration mAb market segments, 2017-2022.

What's Trending in Monoclonal Antibodies also looks at the market in terms of regional markets (United States, Europe, rest of world, global market) and the competitive situation, including company profiles of market leaders such as AbbVie, Johnson & Johnson, and Roche.

Table of Contents

203 Pages
    • Overview
    • Scope and Methodology
    • Market Summary
    • The Development of Monoclonal Antibodies
    • Naming Monoclonal Antibodies
    • DEVELOPMENT Outlook
    • Monoclonal Antibodies by Structure - Mouse, Chimeric, Humanized, Human
    • Market Overview
    • Market Overview
    • Market Overview
    • Other Areas of Treatment
    • Market Influences
    • Reimbursement Landscape: A Deciding Factor for Success
    • The Biosimilar Movement
    • Regional Market Overview
    • Leading Products
    • Market Breakdown of Monoclonal Antibodies
    • Competitor Summary
    • AbbVie
    • Ablynx
    • Agensys
    • Alder Biopharmaceuticals
    • Alexion Pharmaceuticals
    • Allergan
    • Amgen
    • Aptevo Therapeutics
    • AstraZeneca/MedImmune
    • Bayer
    • Biocon Ltd
    • Biogen Inc.
    • BioInvent International
    • Biotest AG
    • Boehringer Ingelheim GmbH
    • CBT Pharmaceuticals
    • Celgene
    • Celldex Therapeutics
    • Celltrion, Inc.
    • Coherus BioSciences, Inc
    • CytoDyn
    • Eisai
    • Eleven Biotherapeutics
    • Eli Lilly & Co.
    • FibroGen Inc.
    • Five Prime Therapeutics
    • Fujifilm Kyowa Kirin Biologics
    • Genmab A/S
    • Gilead Sciences
    • GlaxoSmithKline plc
    • Humanigen, Inc. (previously KaloBios Pharmaceuticals)
    • Immune Pharmaceuticals
    • ImmunoGen Inc.
    • Immunomedics Inc.
    • Innate Pharma
    • InterveXion Therapeutics
    • Johnson & Johnson
    • Kyowa Hakko Kirin Co, Ltd
    • MacroGenics
    • Mapp Biopharmaceutical
    • Merck & Company
    • Merrimack Pharmaceuticals
    • Momenta Pharmaceuticals Inc.
    • MorphoSys
    • Morphotek
    • Mylan N.V.
    • Nascent Biotech
    • Neurimmune
    • Nordic Nanovector
    • Novartis/Sandoz
    • Novimmune SA
    • OncoMed Pharmaceuticals
    • OncoQuest
    • Oncternal Therapeutics
    • Pfizer, Inc.
    • Regeneron Pharmaceuticals
    • Roche
    • Samsung Bioepis Co Ltd
    • Sanofi
    • Seattle Genetics
    • Shire PLC
    • Sorrento Therapeutics
    • TaiMed Biologics
    • Takeda Oncology
    • TESARO
    • TEVA Pharmaceutical Industries Ltd
    • TG Therapeutics
    • ThromboGenics
    • UCB S.A.
    • Unum Therapeutics
    • Vitaeris
    • XBiotech
    • Xencor
    • XOMA
    • Y-mAbs Therapeutics

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us